Pharmaceutical Manufacturing Market

Pharmaceutical Manufacturing Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

150

Base Year:

2022

Oct - 2023

Format:

Report Code:

VMR-2300

Segments Covered

By Molecule Type Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)
By Drug Development Type In-house, Outsource
By Formulation Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations
By Therapy Area Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases
By Prescription Prescription Medicines, Over-the-counter (OTC) Medicines
By Age Group Children & Adolescents, Adults, Geriatric
By Sales Channel Retail, Non-retail
By Route of Administration Oral, Topical, Parenteral, Inhalations, Other Routes of Administration
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 510.5 Billion
Revenue 2030:	USD 863.6 Billion
Revenue CAGR (2023 - 2030):	7.8%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Pharmaceutical Manufacturing Market - Segment Analysis
1. Overview
2. Global Pharmaceutical Manufacturing Market, 2016 - 2028 (USD Million)
3. Global Pharmaceutical Manufacturing Market - by Molecule Type
  1. By Biologics & Biosimilars (Large Molecules)
  2. By Conventional Drugs (Small Molecules)
4. Global Pharmaceutical Manufacturing Market - by Drug Development Type
  1. By In-house
  2. By Outsource
5. Global Pharmaceutical Manufacturing Market - by Formulation
  1. By Tablets
  2. By Capsules
  3. By Injectable
  4. By Sprays
  5. By Suspensions
  6. By Powders
  7. By Other Formulations
6. Global Pharmaceutical Manufacturing Market - by Therapy Area
  1. By Cardiovascular Diseases (CVDs)
  2. By Pain
  3. By Diabetes
  4. By Cancer
  5. By Respiratory Diseases
  6. By Other Diseases
7. Global Pharmaceutical Manufacturing Market - by Prescription
  1. By Prescription Medicines
  2. By Over-the-counter (OTC) Medicines
8. Global Pharmaceutical Manufacturing Market - by Age Group
  1. By Children & Adolescents
  2. By Adults
  3. By Geriatric
9. Global Pharmaceutical Manufacturing Market - by Sales Channel
  1. By Retail
  2. By Non-retail
10. Global Pharmaceutical Manufacturing Market - by Route of Administration
  1. By Oral
  2. By Topical
  3. By Parenteral
  4. By Inhalations
  5. By Other Routes of Administration
11. Global Pharmaceutical Manufacturing Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
12. Market comparative analysis
North America Pharmaceutical Manufacturing Market - Segment Analysis
1. Overview
2. North America Pharmaceutical Manufacturing Market, 2016 - 2028 (USD Million)
3. North America Pharmaceutical Manufacturing Market, by Molecule Type
  1. By Biologics & Biosimilars (Large Molecules)
  2. By Conventional Drugs (Small Molecules)
4. North America Pharmaceutical Manufacturing Market, by Drug Development Type
  1. By In-house
  2. By Outsource
5. North America Pharmaceutical Manufacturing Market, by Formulation
  1. By Tablets
  2. By Capsules
  3. By Injectable
  4. By Sprays
  5. By Suspensions
  6. By Powders
  7. By Other Formulations
6. North America Pharmaceutical Manufacturing Market, by Therapy Area
  1. By Cardiovascular Diseases (CVDs)
  2. By Pain
  3. By Diabetes
  4. By Cancer
  5. By Respiratory Diseases
  6. By Other Diseases
7. North America Pharmaceutical Manufacturing Market, by Prescription
  1. By Prescription Medicines
  2. By Over-the-counter (OTC) Medicines
8. North America Pharmaceutical Manufacturing Market, by Age Group
  1. By Children & Adolescents
  2. By Adults
  3. By Geriatric
9. North America Pharmaceutical Manufacturing Market, by Sales Channel
  1. By Retail
  2. By Non-retail
10. North America Pharmaceutical Manufacturing Market, by Route of Administration
  1. By Oral
  2. By Topical
  3. By Parenteral
  4. By Inhalations
  5. By Other Routes of Administration
11. North America Pharmaceutical Manufacturing Market, by Country
  1. U.S.
    1. U.S. Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. U.S. Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. U.S. Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. U.S. Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. U.S. Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. U.S. Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. U.S. Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. U.S. Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  2. Canada
    1. Canada Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Canada Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Canada Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Canada Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Canada Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Canada Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Canada Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Canada Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  3. Mexico
    1. Mexico Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Mexico Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Mexico Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Mexico Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Mexico Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Mexico Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Mexico Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Mexico Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
Europe Pharmaceutical Manufacturing Market - Segment Analysis
1. Overview
2. Europe Pharmaceutical Manufacturing Market, 2016 - 2028 (USD Million)
3. Europe Pharmaceutical Manufacturing Market, by Molecule Type
  1. By Biologics & Biosimilars (Large Molecules)
  2. By Conventional Drugs (Small Molecules)
4. Europe Pharmaceutical Manufacturing Market, by Drug Development Type
  1. By In-house
  2. By Outsource
5. Europe Pharmaceutical Manufacturing Market, by Formulation
  1. By Tablets
  2. By Capsules
  3. By Injectable
  4. By Sprays
  5. By Suspensions
  6. By Powders
  7. By Other Formulations
6. Europe Pharmaceutical Manufacturing Market, by Therapy Area
  1. By Cardiovascular Diseases (CVDs)
  2. By Pain
  3. By Diabetes
  4. By Cancer
  5. By Respiratory Diseases
  6. By Other Diseases
7. Europe Pharmaceutical Manufacturing Market, by Prescription
  1. By Prescription Medicines
  2. By Over-the-counter (OTC) Medicines
8. Europe Pharmaceutical Manufacturing Market, by Age Group
  1. By Children & Adolescents
  2. By Adults
  3. By Geriatric
9. Europe Pharmaceutical Manufacturing Market, by Sales Channel
  1. By Retail
  2. By Non-retail
10. Europe Pharmaceutical Manufacturing Market, by Route of Administration
  1. By Oral
  2. By Topical
  3. By Parenteral
  4. By Inhalations
  5. By Other Routes of Administration
11. Europe Pharmaceutical Manufacturing Market, by Country
  1. Germany
    1. Germany Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Germany Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Germany Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Germany Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Germany Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Germany Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Germany Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Germany Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  2. UK
    1. UK Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. UK Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. UK Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. UK Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. UK Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. UK Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. UK Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. UK Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  3. France
    1. France Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. France Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. France Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. France Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. France Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. France Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. France Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. France Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  4. Spain
    1. Spain Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Spain Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Spain Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Spain Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Spain Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Spain Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Spain Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Spain Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  5. Italy
    1. Italy Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Italy Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Italy Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Italy Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Italy Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Italy Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Italy Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Italy Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  6. BENELUX
    1. BENELUX Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. BENELUX Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. BENELUX Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. BENELUX Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. BENELUX Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. BENELUX Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. BENELUX Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. BENELUX Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  7. Rest of Europe
    1. Rest Of Europe Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Rest Of Europe Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Rest Of Europe Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Rest Of Europe Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Rest Of Europe Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Rest Of Europe Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Rest Of Europe Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Rest Of Europe Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
Asia Pacific Pharmaceutical Manufacturing Market - Segment Analysis
1. Overview
2. Asia Pacific Pharmaceutical Manufacturing Market, 2016 - 2028 (USD Million)
3. Asia Pacific Pharmaceutical Manufacturing Market, by Molecule Type
  1. By Biologics & Biosimilars (Large Molecules)
  2. By Conventional Drugs (Small Molecules)
4. Asia Pacific Pharmaceutical Manufacturing Market, by Drug Development Type
  1. By In-house
  2. By Outsource
5. Asia Pacific Pharmaceutical Manufacturing Market, by Formulation
  1. By Tablets
  2. By Capsules
  3. By Injectable
  4. By Sprays
  5. By Suspensions
  6. By Powders
  7. By Other Formulations
6. Asia Pacific Pharmaceutical Manufacturing Market, by Therapy Area
  1. By Cardiovascular Diseases (CVDs)
  2. By Pain
  3. By Diabetes
  4. By Cancer
  5. By Respiratory Diseases
  6. By Other Diseases
7. Asia Pacific Pharmaceutical Manufacturing Market, by Prescription
  1. By Prescription Medicines
  2. By Over-the-counter (OTC) Medicines
8. Asia Pacific Pharmaceutical Manufacturing Market, by Age Group
  1. By Children & Adolescents
  2. By Adults
  3. By Geriatric
9. Asia Pacific Pharmaceutical Manufacturing Market, by Sales Channel
  1. By Retail
  2. By Non-retail
10. Asia Pacific Pharmaceutical Manufacturing Market, by Route of Administration
  1. By Oral
  2. By Topical
  3. By Parenteral
  4. By Inhalations
  5. By Other Routes of Administration
11. Asia Pacific Pharmaceutical Manufacturing Market, by Country
  1. China
    1. China Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. China Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. China Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. China Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. China Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. China Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. China Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. China Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  2. Japan
    1. Japan Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Japan Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Japan Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Japan Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Japan Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Japan Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Japan Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Japan Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  3. India
    1. India Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. India Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. India Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. India Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. India Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. India Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. India Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. India Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  4. South Korea
    1. South Korea Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. South Korea Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. South Korea Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. South Korea Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. South Korea Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. South Korea Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. South Korea Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. South Korea Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  5. South East Asia
    1. South East Asia Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. South East Asia Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. South East Asia Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. South East Asia Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. South East Asia Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. South East Asia Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. South East Asia Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. South East Asia Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Rest of Asia Pacific Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Rest of Asia Pacific Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Rest of Asia Pacific Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Rest of Asia Pacific Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Rest of Asia Pacific Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Rest of Asia Pacific Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Rest of Asia Pacific Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
Latin America Pharmaceutical Manufacturing Market - Segment Analysis
1. Overview
2. Latin America Pharmaceutical Manufacturing Market, 2016 - 2028 (USD Million)
3. Latin America Pharmaceutical Manufacturing Market, by Molecule Type
  1. By Biologics & Biosimilars (Large Molecules)
  2. By Conventional Drugs (Small Molecules)
4. Latin America Pharmaceutical Manufacturing Market, by Drug Development Type
  1. By In-house
  2. By Outsource
5. Latin America Pharmaceutical Manufacturing Market, by Formulation
  1. By Tablets
  2. By Capsules
  3. By Injectable
  4. By Sprays
  5. By Suspensions
  6. By Powders
  7. By Other Formulations
6. Latin America Pharmaceutical Manufacturing Market, by Therapy Area
  1. By Cardiovascular Diseases (CVDs)
  2. By Pain
  3. By Diabetes
  4. By Cancer
  5. By Respiratory Diseases
  6. By Other Diseases
7. Latin America Pharmaceutical Manufacturing Market, by Prescription
  1. By Prescription Medicines
  2. By Over-the-counter (OTC) Medicines
8. Latin America Pharmaceutical Manufacturing Market, by Age Group
  1. By Children & Adolescents
  2. By Adults
  3. By Geriatric
9. Latin America Pharmaceutical Manufacturing Market, by Sales Channel
  1. By Retail
  2. By Non-retail
10. Latin America Pharmaceutical Manufacturing Market, by Route of Administration
  1. By Oral
  2. By Topical
  3. By Parenteral
  4. By Inhalations
  5. By Other Routes of Administration
11. Latin America Pharmaceutical Manufacturing Market, by Country
  1. Brazil
    1. Brazil Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Brazil Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Brazil Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Brazil Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Brazil Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Brazil Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Brazil Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Brazil Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  2. Argentina
    1. Argentina Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Argentina Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Argentina Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Argentina Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Argentina Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Argentina Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Argentina Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Argentina Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  3. Rest of Latin America
    1. Rest of Latin America Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Rest of Latin America Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Rest of Latin America Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Rest of Latin America Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Rest of Latin America Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Rest of Latin America Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Rest of Latin America Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Rest of Latin America Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
Middle East & Africa Pharmaceutical Manufacturing Market - Segment Analysis
1. Overview
2. Middle East & Africa Pharmaceutical Manufacturing Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Pharmaceutical Manufacturing Market, by Molecule Type
  1. By Biologics & Biosimilars (Large Molecules)
  2. By Conventional Drugs (Small Molecules)
4. Middle East & Africa Pharmaceutical Manufacturing Market, by Drug Development Type
  1. By In-house
  2. By Outsource
5. Middle East & Africa Pharmaceutical Manufacturing Market, by Formulation
  1. By Tablets
  2. By Capsules
  3. By Injectable
  4. By Sprays
  5. By Suspensions
  6. By Powders
  7. By Other Formulations
6. Middle East & Africa Pharmaceutical Manufacturing Market, by Therapy Area
  1. By Cardiovascular Diseases (CVDs)
  2. By Pain
  3. By Diabetes
  4. By Cancer
  5. By Respiratory Diseases
  6. By Other Diseases
7. Middle East & Africa Pharmaceutical Manufacturing Market, by Prescription
  1. By Prescription Medicines
  2. By Over-the-counter (OTC) Medicines
8. Middle East & Africa Pharmaceutical Manufacturing Market, by Age Group
  1. By Children & Adolescents
  2. By Adults
  3. By Geriatric
9. Middle East & Africa Pharmaceutical Manufacturing Market, by Sales Channel
  1. By Retail
  2. By Non-retail
10. Middle East & Africa Pharmaceutical Manufacturing Market, by Route of Administration
  1. By Oral
  2. By Topical
  3. By Parenteral
  4. By Inhalations
  5. By Other Routes of Administration
11. Middle East & Africa Pharmaceutical Manufacturing Market, by Country
  1. GCC Countries
    1. GCC Countries Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. GCC Countries Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. GCC Countries Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. GCC Countries Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. GCC Countries Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. GCC Countries Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. GCC Countries Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. GCC Countries Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  2. South Africa
    1. South Africa Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. South Africa Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. South Africa Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. South Africa Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. South Africa Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. South Africa Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. South Africa Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. South Africa Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Pharmaceutical Manufacturing Market, By Molecule Type
      1. By Biologics & Biosimilars (Large Molecules)
      2. By Conventional Drugs (Small Molecules)
    2. Rest of Middle East & Africa Pharmaceutical Manufacturing Market, By Drug Development Type
      1. By In-house
      2. By Outsource
    3. Rest of Middle East & Africa Pharmaceutical Manufacturing Market, By Formulation
      1. By Tablets
      2. By Capsules
      3. By Injectable
      4. By Sprays
      5. By Suspensions
      6. By Powders
      7. By Other Formulations
    4. Rest of Middle East & Africa Pharmaceutical Manufacturing Market, By Therapy Area
      1. By Cardiovascular Diseases (CVDs)
      2. By Pain
      3. By Diabetes
      4. By Cancer
      5. By Respiratory Diseases
      6. By Other Diseases
    5. Rest of Middle East & Africa Pharmaceutical Manufacturing Market, By Prescription
      1. By Prescription Medicines
      2. By Over-the-counter (OTC) Medicines
    6. Rest of Middle East & Africa Pharmaceutical Manufacturing Market, By Age Group
      1. By Children & Adolescents
      2. By Adults
      3. By Geriatric
    7. Rest of Middle East & Africa Pharmaceutical Manufacturing Market, By Sales Channel
      1. By Retail
      2. By Non-retail
    8. Rest of Middle East & Africa Pharmaceutical Manufacturing Market, By Route of Administration
      1. By Oral
      2. By Topical
      3. By Parenteral
      4. By Inhalations
      5. By Other Routes of Administration
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. F. Hoffmann-La Roche Ltd. (Switzerland)
2. Novartis AG (Switzerland)
3. GlaxoSmithKline PLC (UK)
4. Pfizer Inc. (U.S.)
5. Merck & Co. Inc. (U.S.)
6. AstraZeneca (UK)
7. Johnson & Johnson (U.S.)
8. Sanofi SA (France)
9. Eli Lilly and Company (U.S.)
10. AbbVie Inc. (U.S.)
11. Thermo Fisher Scientific Inc. (U.S.)
12. Wuxi Apptec (China)
13. Samsung Biologics (South Korea)
14. FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (U.S.)
15. Lonza Group AG (Switzerland)
16. Catalent Pharma Solutions (U.S.)
17. Jubilant Pharmova Limited (India)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 06-Oct-2023

Pharmaceutical Manufacturing Market to Reach Valuation of USD 863.6 Billion by 2030 – Rising Demand for Medication and Healthcare Products Drives the Market

FAQ

Frequently Asked Question

What is the global demand for Pharmaceutical Manufacturing in terms of revenue?

The global Pharmaceutical Manufacturing valued at USD 510.5 Billion in 2022 and is expected to reach USD 863.6 Billion in 2030 growing at a CAGR of 7.8%.

Which are the prominent players in the market?

The prominent players in the market are F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline PLC (UK), Pfizer Inc. (U.S.), Merck & Co. Inc. (U.S.), AstraZeneca (UK), Johnson & Johnson (U.S.), Sanofi SA (France), Eli Lilly and Company (U.S.), AbbVie Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Wuxi Apptec (China), Samsung Biologics (South Korea), FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (U.S.), Lonza Group AG (Switzerland), Catalent Pharma Solutions (U.S.), Jubilant Pharmova Limited (India).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 7.8% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Pharmaceutical Manufacturing include
- Rise in pharmaceutical R&D spending

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Pharmaceutical Manufacturing in 2022.

Pharmaceutical Manufacturing Market

Pharmaceutical Manufacturing Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Pharmaceutical Manufacturing in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Pharmaceutical Manufacturing Market

Pharmaceutical Manufacturing Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Pharmaceutical Manufacturing in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Pharmaceutical Manufacturing Market

Vantage Point Interactive Dashboard